Hemas Holdings Ltd.
CCSELK:HHL.N000030.20
LKR
-0.30
(-0.98%)
ISIN
LK0337N00002
Return %
Stock
S&P 500
1Y
-14.20
14.20
3Y
103.50
81.12
5Y
98.68
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Ashish Chandra
- Full Time Employees
- 6,504
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Colombo Sri Lanka
- IPO Date
- Sep 17, 2009
- Website
- hemas.com
- Similar Companies
- Business
- Hemas Holdings PLC is a Sri Lanka-based diversified conglomerate operating primarily across the consumer goods, healthcare, and mobility sectors. The company operates through three principal business segments: Consumer Brands, Healthcare, and Mobility. The Consumer Brands segment manufactures, markets, and distributes personal care, home care, baby care, beauty care, and educational stationery products; its brand portfolio includes Baby Cheramy and Cheramy (baby toiletries, skin care, feeding accessories, and laundry care), Velvet (beauty soaps, body washes, and body lotions), Clogard (toothpaste, toothbrushes, and oral care treatments), Kumarika (herbal hair oils, shampoos, and hair treatments), Fems (feminine sanitary napkins and wellness products), Diva (laundry detergents, washing powders, and dishwashing products), and Vivya (heirloom-rice-based skincare formulations); through its subsidiary Atlas Axillia Co., the company produces and distributes school and office stationery, writing instruments, drawing books, notebooks, and student educational supplies under the Atlas, Innovate, and Homerun brands. The Healthcare segment encompasses pharmaceutical manufacturing, wholesale healthcare distribution, surgical and diagnostic equipment marketing, and private hospital operations; through Morison Limited, it manufactures prescription pharmaceuticals, branded generics, and over-the-counter remedies; through Hemas Pharmaceuticals, it acts as an exclusive distributor for multinational pharmaceutical, biological, and consumer health companies; through Hemas Surgicals & Diagnostics, it distributes medical devices, diagnostic instruments, and surgical consumables; and through Hemas Hospitals, it operates private multi-specialty secondary and tertiary hospitals alongside outpatient diagnostic laboratory networks in Wattala and Thalawathugoda. The Mobility segment provides ocean shipping agency, freight forwarding, total supply chain management, integrated third-party logistics (3PL), container depot operations, warehousing, and airline passenger and cargo general sales agency (GSA) services. Geographically, Hemas Holdings serves consumers and corporate clients across Sri Lanka, operates manufacturing and marketing subsidiaries in Bangladesh, and exports products across South Asia, Southeast Asia, the Middle East, and East Africa. In recent developments, the company has scaled commercial pharmaceutical production at Morison's WHO-GMP-certified manufacturing facility in Homagama, launching new generic therapeutic formulations for diabetes and cardiovascular conditions; expanded its international personal care manufacturing and distribution footprint in Bangladesh; launched affordable feminine hygiene ranges under Fems to combat period poverty; introduced sustainable and eco-friendly school stationery lines under Atlas Axillia; and expanded its integrated logistics operations with upgraded temperature-controlled warehousing and digitized supply chain services following a strategic re-alignment to focus core capital on Consumer, Healthcare, and Mobility pillars. Founded in 1948, Hemas Holdings PLC is headquartered in Colombo, Sri Lanka.